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The present study aims to evaluate the effects of metronidazole, probiotics oligosaccharide on 
indigenous microflora and bacterial translocation (BT) in protein malnourished rats. Thirty male Wistar 
rats were divided into three groups: protein malnourished rats PM (group1, n = 10) were fed with maize 
only, protein malnourished rats (group 2, n = 10) were received metronidazole and protein malnourished 
rats (group 3, n = 10) were received both metronidazole and probiotics-oligosaccharide for fifteen days. 
Metronidazole (1000 mg/kg/day) was given via an orogastric feeding tube to the second and third 
groups. Lyophilized probiotics-oligosaccharide (0.5 mg/g body weight/day) was given in two doses via 
the same route to the third group. All animals were sacrificed after fifteen days of protein malnutrition 
and cultures of the mesenteric lymph nodes (MLNs), liver, spleen and cecal contents were done. The 
incidence of bacterial translocation (BT) was 30% (3/10) in protein malnourished group 1,60% (06/10) in 
group 2 where protein malnutrition was associated with metronidazole and 25% (2.5/10) in group 3 
whose animals were subjected to protein malnutrition associated with metronidazole and probiotics 
oligosaccharide. A significant increase in the BT incidence was found in group 2 (P < 0.05), while a 
significant decrease was found in group 3 when compared to group 1. The total bacterial count of cecal 
flora was significantly low in group 3 than in group 1 (P < 0.01). These results suggest that the 
incidence of BT in protein malnutrition is increased by using an antibiotic while probiotics-
oligosaccharide decreases this incidence in protein malnutrition induced by antibiotic. Thus, we 
conclude that probiotics-oligosaccharide can effectively protect the intestinal mucosa and prevent BT 
in protein malnourished infants. 
 
Key words: Bacterial translocation, protein malnutrition, probiotics oligosaccharide, metronidazole and 





In light of the wide usage of antibiotic drugs in developing 
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the effects of malnutrition on the disposition of antibiotics. 
In the world, severe acute protein malnutrition (PM) affects 
approximately 13 million children under the age of 5 and it is 
associated with 1 - 2 million preventable child deaths each 
year (Collins, 2007). Use of antibiotics promotes the 
emergence of resistant organisms and multiple-antibiotic 
resistance  has  become  a  major   public   health   issue. 
 
 





ethanol) is widely used in the treatment of parasitic 
diseases and mainly against anaerobes, including Bacte-
roïdes (Freeman et al., 1997). Metronidazole at the doses 
used (1 mg/ml drinking water ad libitum) disrupts the 
intestinal bacterial flora resulting in the destruction of 
strict anaerobic bacteria and therefore, an overgrowth of 
enterobacteria in the cecal (Berg, 1981). This allows 
studying the simultaneous influence of malnutrition and 
antibiotics. There has been a growing interest in the 
effects of malnutrition on drug metabolism and pharma-
cokinetics (Jung and Shahl, 1986). 
Although malnutrition itself cannot be treated by drug 
therapy, it can induce situations where drugs are the 
primary form of treatment. The treatment of infections is 
the most common and severe drug-related problem asso-
ciated with protein malnutrition.  
In addition, probiotics were used in conjunction with 
antibiotic therapy to prevent or lessen the severity of 
antibiotic-associated diarrhea in children (Vanderhoof et 
al., 1999), although a meta-analysis of this issue showed 
significant problems in study design in several studies 
(Cremonini et al., 2001). 
A malnourished individual is known to be much more 
susceptible to infections. In light of the wide usage of 
antibiotic drugs in developing countries, it becomes extre-
mely important to determine the effects of malnutrition on 
the disposition of antibiotics (Jung and Shahl, 1986).  
The gut microflora is an important constituent of the 
intestinal mucosa barrier and this has led to the concept 
of probiotics therapy, that is, the application of potentially 
beneficial microorganisms (Fuller, 1992). Probiotics is a 
microbial dietary adjuvant that beneficially affects the 
host physiology by modulating mucosal and systemic 
immunity, as well as improving nutritional and microbial 
balance in the intestine tract. They are nonpathogenic 
microorganisms that, when administered in adequate 
amounts, confer a health benefit on the host. Probiotics 
bacteria are noninvasive, yet they need to interact with 
gastrointestinal (GI) epithelial cells to elicit their 
immunomodulatory effects. Probiotics have been shown 
to induce various epithelial cell responses by competing 
with pathogenic bacteria for host adhesion binding sites, 
improving epithelial cell barrier function (Myllyluoma et 
al., 2008). 
Probiotics and prebiotics can be used to either prevent 
or reduce the severity of microbe-induced gut 
inflammation. The best known prebiotics are fructo-
oligosaccharides, sugars of plant origin. It has interesting 
properties such as stimulating the growth of probiotics 
and renewal of cells in the intestinal mucosa. 
PROBIONAT® is a product of both a probiotics and 





 lation of the intestinal flora, especially during an antibiotic 
in case of diarrhea or intestinal parasites. For all the 
positive effects of probiotics, three conditions can be met, 
a cocktail of the best micro-organisms in sufficient 
quantities and especially live. 
Protein malnutrition disrupts the normal ecology of the 
microflora affecting strictly anaerobes (Tannock and 
Savage, 1974; Poxton et al., 1997), impairs host immune 
response and antibacterial defenses (Reynolds et al., 
1992; Chandra, 1993), enhances the susceptibility to 
infection and leads to mucosal atrophy (Reynolds et al., 
1996). Malnutrition is a common problem for critical ill 
patients and nutritional support is mandatory. 
The effect of probiotics oligosaccharide in combination 
with antibiotics on protein malnutrition has not been 
proposed until now as an alternative to the use of 
prophylactic antibiotics. Antibiotic prophylaxis is intended 
to prevent the potential of bacterial contamination as a 
situation risk. It is unknown if modification of the intestinal 
flora with such a multispecies probiotics mixture with 
fructo oligosaccharide reduces bacterial overgrowth and 
bacterial translocation from the gut and, consequently, 
alters the course of disease. Therefore, the present study 
was as an attempt to assess if modification of intestinal 
flora by a specifically designed, multispecies probiotics 
mixture with fructo oligosaccharide changes disease 




MATERIALS AND METHODS  
 
Animals and diets 
 
Thirty male Wistar rats weighing 60 - 70 g and aged 28 days were 
used. All animals were obtained with approval from the Animal 
Research Center of Bab Ezzour University, Algeria. The rats were 
housed in stainless-steel cages in an animal room maintained at 22 
± 2°C on a 12-h light cycle. After three days of acclimatization, they 
had free access to water ad libitum and conventionally, pellet food 
(UAR, Villemoisson-sur- Orge, France). The conventionally diet is 
containing proteins, fat, carbohydrate, vitamin and minerals (Table 
1). 
We propose here a new experimental model of malnutrition, 
based on exclusive use of maize. This diet, similar to that 
consumed by the severely malnourished children in poor countries, 
is severely deficient in essential acid amine and vitamins (Ribeiro et 
al., 1998).  
During fifteen days of experimental feeding period, animals were 
divided into three groups of 10 rats each. A protein malnourished 
rats (group 1, n = 10) were fed only with maize, a protein 
malnourished rats (group 2, n = 10) were received an antibiotic 
(Metronidazole) and a protein malnourished animals of group 3 (n = 
10) received both Metronidazole and Probiotics Oligosaccharide. 
The malnourished rats of the three groups were fed with maize (diet 
poly-deficient in essential amino acids) with 10 g/kg of rat/day (EPE 
Grope Avicole de l’Ouest, Mostaganem, Algeria); the composition of 
 
 




Table 1. Standard diet for rats (UAR, Villemoisson-sur- Orge, France). 
 
Ingredients Cereals and starchy product   
Co-products of the cereals transformation   
Oil cakes and other nitrogenized products of vegetable origin  
Nitrogenized product  
Mineral substances  
Oils and grease  
Analytical Components  Gross products 23% 
Rough fat content 0.43% 
Crude fiber 4% 
Moisture 2% 
Rough ashes 5.5% 
Insoluble ashes in HCl 2% 
Copper 30 mg/kg 
Vitamins A 12,000 UI/kg 
D3 3,000 UI/kg 
E 30 mg/kg 
 




Table 2. Composition of maize (EPE Groupe Avicole de l’Ouest, Mostaganem, Algeria). 
 
Humidity Protein Grease Ashes Fiber Carbonhydrate Calories 
12.2 8.4 4.5 1.1 1.3 73.9 370 
 




maize was given in (Table 2). Food intake was measured daily at 
17 h. Induction of malnutrition after 15 days with this diet was 
published earlier (Dock et al., 2003; Dock-Nascimento et al., 2007). 
Metronidazole (Hikma Pharmaceuticals, Jordan) was given via 
orogastric feeding tube to the rats of groups 2 and 3 for 15 days 
with the dose of 1 g/kg of animal/day). A complex of lyophilized 
probiotics (Lactobacillus acidophilus, Lactobacillus rhamnosus, 
Bifidoboctenium lactis, Bifidoboctenium longum, Bifidoboctenium 
bifidum, Steptococcus thermophilus) and Fructo-Oligosaccharides 
(PROBIONAT® Safetynat Limited Epps Building Bridge Road, 
France) in the form of a capsule contained about 109 germs in 
lyophilisate of 390 mg. It was given as three doses per day via 
orogastric feeding tube (1 mg/g of body per day) to the rats of group 
3 (10 mg/ 10 ml). On the day 15 of this treatment, the animals were 
sacrificed by cervical dislocation and a 0.5 ml blood sample was 
collected from the inferior vena cava for blood cultures. 
Using sterile procedures, the chest and abdominal cavities were 
reflected with sterile forceps and the exposed viscera were 
swabbed with a sterile, cotton-topped applicator stick, which was 
then placed in a tube of brain-heart infusion. The tube was 
incubated aerobically at 37°C for 24 h to test the bacterial 
contamination of the viscera. 
The MLNs, spleen and liver were removed and all organs were 
weighed separately. The MLN complex was placed in a sterile 
grinding tube and homogenized with 9 volume of brain– heart 
infusion using sterile ground-glass stoppers (Heimo et al., 2001). To 
determine the bacterial concentrations of homogenates, each organ 
was diluted in decimal steps up to 1.105 in a sterile solution. After 
manual grinding, 1 ml of the homogenate was transferred into a 
tube containing 9 ml of physiologic serum; from this dilution 100 µl 
aliquots were plated on DRIGALSKI agar plates for enterobacteria 
culture (Sanofi, Diagnostic Pasteur; France). Spleen and liver was 
analyzed in the same way as the MLNs. All agar plates for aerobic 
culture were incubated at 37°C under aerobic conditions for 1 day 
and then interpreted. The gram-negative enteric was identified 
using the API 20 E system (Analytab Products, Plainview, New 
York). 
Quantitative culture results were determined by the number of 
Colony Forming Units per gram of tissue, calculated from the 
dilutions of organ homogenate and positive tissue cultures. We did 
not study obligate anaerobic because these organisms are rare 
members of the intestinal flora of rodents early in life (Raibaud P, 
1988) and because they have a low tendency to translocate to extra 
intestinal sites (Stefen EK et al., 1988; Stefen EK et al., 1983).  The  
 
 




Table 3. Incidence and sites of bacterial translocation (BT) in each group after 15 days of treatment. 
 
Group Incidence of 
BT 
MLN Spleen Liver Blood 
1. PM 3/10 (30%) 2/10 (20%) 1/10 (10%) 0/10 (0%) 0/10 (0%) 
2. PM + antibiotic 6/10 (60%)* 4/10 (40%) ‡ 2/10 (20%) 3/10(30%) ¶ 0/10 (0%) 
3. PM + antibiotic + 
Probiotics-Oligosaccharide 
2.5/10 (25%) † 3/10 (30%) † 0/10 (0%) 0/10 (0%) 0/10 (0%) 
 
PM, protein-malnourished group; BT, bacterial translocation; MLN, mesenteric lymph nodes. 
*P < 0.01 compared to group 1, †P < 0.05 compared to groups 1 and 2, ‡P < 0.05 compared to group 1 and ¶ P < 0.05 compared to 




Mesenteric Lymph Nodes (MLNs), spleen, liver and cecal contents 
were removed and homogenized for quantitative cultures. The 
colony-forming units (CFU) of bacteria per gram of tissue were 




Data were expressed as means ± standard error of the mean. The 
differences between the different groups were evaluated by chi 
square analysis with the Yates correction. Continuous data are 
expressed as mean 6 SEM and analyzed with analysis of variance 






The incidence of bacterial translocation was 30% (3/10) 
in protein-malnourished group 1 (PM), 60% (6/10) in rats 
of group 2 (where PM was associated with 
metronidazole) and 25% (2.5/10) in group 3 (where 
protein malnutrition was associated with metronidazole 
and probiotics oligosaccharide) (Table 3). The incidence 
of BT in group 3 was not significantly different from that of 
group 1 (P > 0.05). The same result was obtained when 
comparing group 2 to group 1 (P > 0.05). The difference 
in the incidence of BT between groups 2 and 3 was 
significant (P < 0.05), 60% (6/10) in group 2 and 25% 
(2.5/10), in group 3. 
Bacterial translocation was detected only in the MLNs 
(3/10, 30%) of the rats of group 3 which were treated with 
probiotics oligosaccharide. However, it was detected in 
the MLNs (4/10, 40%), spleen (2/10, 20%) and liver 
(3/10, 30%) of group 2. The incidence of BT was 
significantly high in the MLNs of group 2 than that of 
group 1 (P < 0.05). Regarding the liver, the same result 
was obtained in group 2 comparing to groups 1 and 3 (P 
< 0.05). The incidence of BT in the MLNs was not 
significantly different between groups 2 and 3 (P > 0.05), 
or between groups 1 and 3 (P > 0.05). These data 
indicated that BT did not spread beyond the MLNs in 
protein    malnourished    rats    treated    with    probiotics  
Table 4. Number of translocating bacteria in terms of FCU per 
gram of mesenteric lymph nodes in each group after 15 days 
of treatment. 
 
Group 1 Group 2 Group 3 
57 ± 6 160 ± 23 11 ± 3 
 
Mean ± standard error of mean × 103 colony-forming units per 
gram tissue of MLNs.  




oligosaccharide (group 3). 
The results of quantitative MLNs cultures are shown in 
Table 4. Although the number of translocating bacteria 
per gram of MLNs was decreased by the administration 
of probiotics oligosaccharide, there was a significant high 
difference between groups 2 and 1 (P < 0.001) and between 
groups 3 and 1 (P < 0.05). In addition, the difference bet-
ween groups 2 and 3 was significantly high (P < 0.001). 
There was a significant difference between groups 1 and 
2 (400 ± 95 UFC/g Vs 160 ± 43 UFC/g, P < 0.05) as 
shown in Table 5. The total bacterial counts, Gram-
negative and Gram-positive, of cecal flora were signi-
ficantly low in group 1 than that in group 3 (400 ± 95 
UFC/g versus 36 ± 4 UFC/g, P < 0.001). 42% of the total 
bacterial count was Gram-negative in group 1, 51% in 
group 2 and 13% in group 3. Metronidazole caused a 
slight overgrowth of Gram-negative bacteria in group 2. 
Otherwise, this decrease in the Gram-negative population 
of cecal flora was significant (P < 0.01). No micro-





These results suggest that protein-malnutrition induced 
translocation of enterobacteria. Metronidazole acted 
specifically on the strict anaerobic bacteria by reducing 
their numbers in cecal flora which explains the high rates 
of overgrowth and translocation of enteric bacteria  in  the  
 
 




Table 5. Quantitative results of Gram-negative, Gram-positive and total bacteria in cecal cultures for each group after 
15 days of treatment. 
 
Group Gram-negative Gram-positive Total 
1. PM 280 ± 70 (42%) 120 ± 35 (28%) 400 ± 95 
2. PM + antibiotic 95 ± 25* (51%) 65 ± 28* (35%) 160 ± 43* 
3. PM + antibiotic +  Probiotics-Oligosaccharide 15 ± 3** (13%) 21 ± 3** (65%) 36 ± 4** 
 
Mean ± SEM X 102 colony-forming units per gram cecal content. 
 *P < 0.05 and **P < 0.01 compared to group 1. 
 
 
malnourished group received metronidazole. 
In this context, the current observation is that the PM 
and the PM particularly associated with metronidazole 
results in overgrowth cecal bacteria. This bacterial 
overgrowth is most marked in the Gram negative. These 
levels of intestinal bacterial population help to explain the 
collapse of the strictly anaerobic bacterial flora by the use 
of metronidazole and the consequent apparition of 
bacterial translocation in the GLM, spleen and liver. 
In previous studies, we found that protein malnutrition 
and malnutrition associated with metronidazole pro-
mote bacterial overgrowth in cecal and translocation 
of enterobacteria to MLNs (Benakriche et al., 2008).  
Berg and Garglinton (1979) demonstrated that 
penicillin, clindamycin, or metronidazole given orally 
to specific pathogen-free mice for 4 days decreased 
the cecal population of indigenous bacteria, espe-
cially anaerobic bacteria. A decreasing anaerobic 
population allows the cecal overgrowth of indi-
genous, Gram-negative facultative anaerobic enteric 
bacilli and enhances BT to the MLNs. Berg et al. 
(1988) demonstrated that a combination of anti-
biotics and immunosuppressive drugs promotes the 
systemic spread of translocating bacteria, resulting 
in lethal sepsis. Generally, metronidazole is considered 
as a safe drug because of its relative high therapeutic 
index and limited duration of treatment. Deitch et al. 
(1985) reported that the administration of antibiotics 
reduces the levels of indigenous GI tract flora and 
delays colonization by indigenous bacteria in the 
protein malnutrition wound.  
However, Beaugerie and Petit (2004) postulated that 
giving oral antibiotic treatment to protein malnou-
rished victims disrupts the ecological balance of 
indigenous bacterial flora and causes the intestinal 
overgrowth or colonization of the intestines by exo-
genous pathogens such as Candida sp., 
Pseudomonas aeruginosa, or Staphylococcus sp. 
Based on this theoretical suggestion, the same 
researchers investigated the effects of oral antibi-
otics on bacterial overgrowth and bacterial translo-
cation in protein malnourished rats. Deitch et al. 
(1985) found that the cecal overgrowth of enteric 
bacilli caused an enhanced BT after the admini-
stration of Metronidazole (500 Units/ml) in PM rats, 
but the mean of enteric cecal population was 
significantly decreased by the administration of high 
dose of penicillin (1500 Units/ml). All of these 
studies demonstrate that oral antibiotics given in a 
dose dependent manner may inhibit the growth of 
anaerobic bacteria and allow intestinal overgrowth 
of facultative anaerobic Gram-negative bacilli. 
Therefore, the administration of oral antibiotics may 
enhance BT to the MLNs and other organs after PM, 
which impairs both humoral and cellular immunity in 
addition to the damage of local barriers. In the pre-
sent study, we found that oral antibiotic treatment 
enhances BT and promotes the spread of trans-
locating bacteria to the liver in PM rats. However, 
antibiotic treatment is usually required in the treat-
ment of the inflammatory victims. Bacterial overgrowth 
in the small intestine has been documented in children 
with severe malnutrition and might contribute directly to 
ineffective solubilisation, digestion and absorption of lipid 
(Murphy et al., 2002). 
Despite knowledge in the area of overgrowth and 
intestinal bacterial translocation, probiotics and prebiotics 
remain a hot topic. They are the subject of several 
studies which have shown in mice and rats that some 
probiotics like S. boulardii, B. longum, P. acnes, L. 
helveticus, L. rhamnosus and oligosaccharide have a 
protective effect against bacterial translocation. In 
addition, it has been shown that fructo-oligosaccharide 
not only have a protective effect against bacterial trans-
location but also stimulates the proliferation of Bifido-
bacteria and lactobacilli. 
It was reported that protein malnutrition decreases the 
number of lactobacilli and strict anaerobic bacteria of the 
endogenous flora resulting in enterobacteria overgrowth 
in cecal flora (Poxton et al., 1997). 
Recent studies have shown that probiotics, which 
have been used in the treatment of intestinal 
disorders, antibiotic-associated diarrhea and 
Clostridium difficile colitis, are effective for maintaining  
 
 




intestinal equilibrium and reducing BT. Probiotics 
promote an increasing anaerobic population of 
gastrointestinal tract flora (Duffy, 2000; Mattar et al., 
2001) but anaerobic bacterial overgrowth may not be 
important for BT because anaerobic bacteria rarely 
translocate to the MLNs. On the other hand, anae-
robic bacterial overgrowth have many beneficial 
effects such as: strengthening gut mucosal barrier 
function, balancing microbial ecology, adhering to 
the intestinal mucosa, impeding invasive pathogens, 
metabolizing dietary proteins and enzymes by intes-
tinal microflora and promoting resilience of the 
epithelium to gut mucosal permeability. Collins and 
Gibson (1999) reported that small-bowel colonization 
by Escherichia coli K1A and BT was decreased by 
the administration of the probiotics oligosaccharide 
and suggested that probiotics oligosaccharide may be 
used for the treatment of BT and sepsis. 
It has been recently shown that impaired gut barrier 
and mucosal immune function by malnutrition can be 
reversed by L. casei used as an oral adjuvant of 
renutrition diet. The clinical significance of these findings 
will be important, as well as improving mucosal immunity, 
may also induce protection against enteropathogens 
(Gauffin et al., 2004). Probiotics can protect the intestine 
by competing with pathogens for attachment, strength-
ening tight junctions between enterocytes and enhancing 
the mucosal immune response to pathogens (Lei and 
Walker, 2001). 
Hirofumi et al. (1999) demonstrated that two kinds of 
probiotics derived from different bacterial genera 
enhanced epithelial cell proliferation of the gut without 
altering the gross population levels of cecal microflora. In 
humans in vivo, lack of protective effect of probiotics (L. 
plantarum 299V) on bacterial translocation to lymph 
nodes was confirmed by the same team and same 
methodology for combining oligosaccharide with L. 
acidophilus, B. lactis Bb12, S. thermophilus and L. 
bulgaricus (Anderson et al., 2004). 
Remarkably, FOS dose-dependently increased 
salmonella numbers in cecal contents and mucosa and 
caused a major increase in infection-induced diarrhea. In 
addition, FOS enhanced translocation of salmonella. 
Thus, in contrast to most expectations, FOS dose-
dependently impairs the resistance to salmonella 
infection in rats (Sandra et al., 2003).  
L. fermentum KLD has previously been used as both a 
prophylactic and therapeutic agent in the treatment of 
gastrointestinal disturbances and is an interesting 
candidate probiotic strain (Marteau et al., 2001). 
Zaouche et al. (2000) investigated the effects of S. 
boulardii on bacterial overgrowth and translocation in 





did not modify bacterial overgrowth and 
translocation, but it enhanced the functional 
adaptation of the remaining intestinal segments. 
Another study by Berg et al. (1993) investigating the 
effects of S. boulardii on the translocation of C. 
albicans in antibiotic-decontaminated specific patho-
gen free mice revealed that it decreased the 
incidence of C. albicans translocating to the MLNs, 
liver, kidneys and also the number of translocating 
C. albicans per gram MLNs, spleen, and kidneys. 
The present study, which was conducted to 
evaluate the effects of probiotics oligosaccharide on 
BT in protein malnutrition associated with metro-
nidazole treatment, showed that probiotics oligo-
saccharide significantly decreased the population of 
Gram-negative bacteria in cecal flora. Although we 
could not examine the anaerobic flora, these data 
correlate with that of other reports in which 
probiotics increase the anaerobic bacterial count 
and decrease the Gram-negative facultative anae-
robic and aerobic bacteria count in the GI tract 
(Mattar et al., 2001; Ishibashi and Yamazaki, 2001). 
Anaerobic bacteria are generally decreased by 
antibiotic treatment and this ecological imbalance 
allows Gram negative bacteria to proliferate and 
enhances BT (Berg, 1981). The results of our study 
suggest that probiotics oligosaccharide may coun-
teract this undesirable side effect of antibiotics. 
Interestingly, the incidence of BT in the rats treated 
with probiotics oligosaccharide (group 3) was not 
significantly higher than that of the group 1, but was 
significantly higher than that of the rats given the 
antibiotic alone (group 2). Although there was no 
significant difference in the incidence of BT and the 
number of translocating bacteria per gram of MLN 
between groups 2 and 3, we found that probiotics 
oligosaccharide decreased the incidence of BT from 
that which occurred in group 1 and also decreased 
the number of translocating bacteria. Furthermore, 
the administration of probiotics oligosaccharide 
ensured that BT was limited to the MLNs, whereas it 
extended to the liver in rats not given probiotics 
oligosaccharide. Selection of strains was based on their 
in vitro antibacterial and immunomodulatory properties. L. 
acidophilus, L. rhamnosus, B. lactis, B. longum, B. 
bifidum, S. thermophilus and fructo-oligosaccharides 
were selected for their ability to suppress the growth of 
Gram- negative bacteria and their antimicrobial effects.  
The lower incidence of BT in the rats given oral 
probiotics oligosaccharide may not only related to 
improved intestinal ecological balance, but also to 
the effects of probiotics oligosaccharide on host 







production and secretion of intestinal s-IgA, enhan-
cing both phagocytic activity and the maturation of 
enterocytes. 
Protein malnutrition is known from biopsy studies to be 
associated with villous atrophy, decreased villous-crypt 
ratio and increased cellularity of the lamina propria. 
Although severe mucosal injury occurs only in a 
proportion of malnourished children, it is more common in 
kwashiorkor; possibly due to the effect of protein deple-
tion on mucosal recovery (Viteri et al., 1973; Brunser et 
al., 1968; Bhan, 1996), atrophy of intestinal villi facilitates 
the breakdown of the mucosal barrier and thus, trans-
location of bacteria from endogenous flora. Abnormal 
intestinal permeability in kwashiorkor correlates with 
disease severity and improves only slowly with nutritional 
rehabilitation (Brewster et al., 1997).  
On the other hand, abnormal intestinal permeability is a 
feature of bacterial translocation in malnourished adult 
patients with multi-organ failure secondary to trauma, 
sepsis or burns (Deitch, 1990). 
In conclusion, probiotics oligosaccharide may protect 
the balance of GI tract flora by inhibiting the growth 
of Gram-negative bacteria and assisting the growth 
of anaerobic bacteria. On the other hand, it may 
enhance the host immune responses. These effects 
of probiotics oligosaccharide may lower the incidence 
of BT and the number of translocating bacteria in 
protein malnourished victims being treated with 
metronidazole. Thus, probiotics oligosaccharide may be 
effective in preventing BT to the MLNs and other 
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